SlideShare a Scribd company logo
1 of 51
Download to read offline
Acute onset hemiplegiaAcute onset hemiplegia
Dr Surya KumarDr Surya Kumar
 Paralysis of one half of the bodyParalysis of one half of the body
CompleteComplete
IncompleteIncomplete
CrossedCrossed
Anatomy of brainAnatomy of brain
PhysiologyPhysiology
 CMRoCMRo22 is 3.5ml/100mgis 3.5ml/100mg
 Glucose storage upto 90 minGlucose storage upto 90 min
 CBF 30-60ml/100mg <3yrCBF 30-60ml/100mg <3yr
 105-100ml/100mg in 3 -10 yr105-100ml/100mg in 3 -10 yr
 2.5-2.7/100,000 population2.5-2.7/100,000 population
IncidenceIncidence
EtiologyEtiology
 Cardiac ---CCHD, IE, RHD, MyxomaCardiac ---CCHD, IE, RHD, Myxoma
 Blood dyscrasia---Blood dyscrasia---
 Primary vascular disease AcutePrimary vascular disease Acute
infantile hemiplegia, MoyaMoya, Takayasu,infantile hemiplegia, MoyaMoya, Takayasu,
hemiplegic Migraine, fibromuscularhemiplegic Migraine, fibromuscular
Dysplasia,Dysplasia,
 Collagen Vascular Disease PAN,Collagen Vascular Disease PAN,
SLESLE
 Infectious DiseaseInfectious Disease

 Metabolic DiseaseMetabolic Disease
Homocystinuria,MELAsHomocystinuria,MELAs
 TraumaTrauma
Carotid Dissection, Air Embolism, FatCarotid Dissection, Air Embolism, Fat
Embolism, Vertebral occlusionEmbolism, Vertebral occlusion
 Vascular MalformationVascular Malformation
Aneurysm, arteriovenous Malformation,Aneurysm, arteriovenous Malformation,
Vein of galen malformation,Vein of galen malformation,
 Neurocutaneous syndromeNeurocutaneous syndrome
Sturge WeberSturge Weber
 IschemicIschemic
 HemorragicHemorragic
 Share equal proportion of incidenceShare equal proportion of incidence
Ischemic strokeIschemic stroke
 Cardiac disease 19%Cardiac disease 19%
 Coagulation Disorder 14%Coagulation Disorder 14%
 Dehydration 11%Dehydration 11%
 Infection 6%Infection 6%
 Vasculitis 7%Vasculitis 7%
 Dissection 5%Dissection 5%
 Cancer 4%Cancer 4%
 Metabolic disorder 3%Metabolic disorder 3%
 Moyamoya ,SCA, 2%Moyamoya ,SCA, 2%
 MISC 4%MISC 4%
 No risk factor 21%No risk factor 21%
AISAIS
Vulnerable sitesVulnerable sites
 DiencephalonDiencephalon
 Watershed aresWatershed ares
SymptomsSymptoms
 Focal neurological deficitFocal neurological deficit
 SeizureSeizure
 MigraineMigraine
 FeverFever
 LethargyLethargy
 HeadacheHeadache
 DYstoniaDYstonia
 Age relate and associted conditionsAge relate and associted conditions
Cadiac disorderCadiac disorder
 CHDCHD
 RHDRHD
 Prosthetic ValveProsthetic Valve
 Shunts,Shunts,
 Patent foramen ovalePatent foramen ovale
causescauses
 PolycythemiaPolycythemia
 AnemiaAnemia
 ArrythmiaArrythmia
 EndocarditisEndocarditis
IncidenceIncidence
 Exact Data is not availableExact Data is not available
 Upto 9% undergoing fontan surgeryUpto 9% undergoing fontan surgery
 50% occurred within 72 hr of50% occurred within 72 hr of
surgerysurgery
Hematological and hypercoagubleHematological and hypercoaguble
statesstates
 22ndnd
most important causemost important cause
 2 to 7% of young patient2 to 7% of young patient
 Factor v leiden mutation,Factor v leiden mutation,
homocystinemia, deficiency ofhomocystinemia, deficiency of
protein c and protein sprotein c and protein s
Sickle cell anemiaSickle cell anemia
 300per 100,000 sickle cell patient300per 100,000 sickle cell patient
 Above 5 yrAbove 5 yr
Silent infarcts are presentSilent infarcts are present
 Associated with seizures, cranialAssociated with seizures, cranial
nerves ,cognitive declinenerves ,cognitive decline
 Prone for recuurences, chronicProne for recuurences, chronic
seizure disorderseizure disorder
 Keep good hydrationKeep good hydration
 Transfusion to keep HbS <30%Transfusion to keep HbS <30%
InfectionInfection
 5 to 12 % of meningitis5 to 12 % of meningitis
 Systemic infectionSystemic infection
post varicella angiopathy,post varicella angiopathy,
pneumonia, borrelia, HIV,pneumonia, borrelia, HIV,
helicobacter,helicobacter,
 May occur after weeks to months ofMay occur after weeks to months of
infectioninfection
 Post varicellea and herpes isPost varicellea and herpes is
commoncommon
Moya moyaMoya moya
 Chronic,prgrssive,stenotic disease ofChronic,prgrssive,stenotic disease of
arteryartery
 Mainly females are involved. 6 timesMainly females are involved. 6 times
 Multiple telengtesia seen in brainMultiple telengtesia seen in brain
mainly in basal ganglonmainly in basal ganglon
 seizure seen in 335 of patientsseizure seen in 335 of patients
 Recurrent ischemic attack, mentalRecurrent ischemic attack, mental
retardation,,infarction on CTretardation,,infarction on CT
 Treatment is surgeryTreatment is surgery
vasculitisvasculitis
 Takayasu, SLE, MCTD,PANTakayasu, SLE, MCTD,PAN
 Present with associated symptomsPresent with associated symptoms
 Steroid and immunotherapySteroid and immunotherapy
MetabolicMetabolic
 Homocystenemia, MELA, FamilialHomocystenemia, MELA, Familial
HypercholesteremiaHypercholesteremia
 Family history, and charactersticsFamily history, and characterstics
featurefeature
MigraineMigraine
 More common in femalesMore common in females
 FamilialFamilial
 Occasionaly permanent deficitOccasionaly permanent deficit
TraumaTrauma
 Dissecting aneurysm in arteryDissecting aneurysm in artery
 Barbershop,fall on pencil in mouth,Barbershop,fall on pencil in mouth,
popstick,barbershoppopstick,barbershop
 Symtoms come after 1 to 2 daysSymtoms come after 1 to 2 days
Sinovenous thrombosisSinovenous thrombosis
Risk factorsRisk factors
 Prothrombotic disorder 30%Prothrombotic disorder 30%
 Dehydration 30%Dehydration 30%
 Sysystemic infection 8-10%Sysystemic infection 8-10%
 Head and neck infection 9%Head and neck infection 9%
 Rest by cardiac, leukemia,perinatalRest by cardiac, leukemia,perinatal
complication, Drugscomplication, Drugs
featuresfeatures
 Seizures, lethargy,jitterySeizures, lethargy,jittery
 Dilated scalp veins, anterior fontanel,Dilated scalp veins, anterior fontanel,
eyelid swellingeyelid swelling
 Headche,Headche,
OutcomeOutcome
 53% normal53% normal
 25% neurological deficit and seizure25% neurological deficit and seizure
 5% seizure alone5% seizure alone
 9% died9% died
 Perspective study of 80 infantsPerspective study of 80 infants
hemorrhagehemorrhage
 Congenital vascular anamolyCongenital vascular anamoly
 VasculopathiesVasculopathies
 Systemic diseaseSystemic disease
 TraumaTrauma
 Hematological disodersHematological disoders
Intracerebral hemorrhageIntracerebral hemorrhage
 At the entry point of brainAt the entry point of brain
 Hematoma and cerebral edemaHematoma and cerebral edema
produces mass like lesionproduces mass like lesion
FeaturesFeatures
 Severe headache,Severe headache,
 SeizuresSeizures
 Focal signsFocal signs
 Decrease in conciousnessDecrease in conciousness
 AtaxiaAtaxia
 Dysconjugate gaitDysconjugate gait
 comacoma
Risk factorRisk factor
 Trauma most commonTrauma most common
 Vascular malformationVascular malformation
 Degenerative vasculopathyDegenerative vasculopathy
 Hemophilic disorderHemophilic disorder
Subarachnoid hemoorrhageSubarachnoid hemoorrhage
 Ateries forming circle of willis andAteries forming circle of willis and
surrounding itsurrounding it
 Circle of willis seen more in adulutCircle of willis seen more in adulut
 Erythrocytes in subarachnoid spaceErythrocytes in subarachnoid space
can cause severe spasm leading tocan cause severe spasm leading to
secondary ishemic infarctionsecondary ishemic infarction
FeatureFeature
 Severe headache, neck rigidity,Severe headache, neck rigidity,
 Low grade feverLow grade fever
 LeckocytosisLeckocytosis
 Raised ICTRaised ICT
Malformation of vein of galenMalformation of vein of galen
ApporachApporach
 Through examinationThrough examination
 HeaHea
 FaceFace
 EyesEyes
 EarsEars
 Paranasal sinusesParanasal sinuses
 Oral cavityOral cavity
 neckneck
 SkinSkin
 Bone and jointsBone and joints
 ExtremitiesExtremities
 AnthropometryAnthropometry
 vitalsvitals
 Per abdomenPer abdomen
 CVSCVS
 Suppurative lung diseaseSuppurative lung disease
InvestigationInvestigation
 CBC,Platelet,ESRCBC,Platelet,ESR
 LFTLFT
 CholesterolCholesterol
 Coagulation profileCoagulation profile
 ECG, chest X xay,ECG, chest X xay,
 USG abdomenUSG abdomen
 VDRL/HIVVDRL/HIV
 UrinanalysisUrinanalysis
 Lactate/pyruvateLactate/pyruvate
 Ana,RA, anti cardiolipinAna,RA, anti cardiolipin
 Lumbar puntureLumbar punture
 CTCT
 MRIMRI
 AngiographyAngiography
TherapyTherapy
 Absence of RCTAbsence of RCT
 Adapted from adultsAdapted from adults
 Treat underlying risk factorTreat underlying risk factor
 Prevent recurrencePrevent recurrence
Consensus on……Consensus on……
 Sickle cell diseaseSickle cell disease
 Acute therapyAcute therapy
• Exchange transfusionExchange transfusion
 Preventive therapyPreventive therapy
• Blood transfusion every 3-6 weeks toBlood transfusion every 3-6 weeks to
maintain HbS<30%maintain HbS<30%
• ?HU, stem cell transplant?HU, stem cell transplant
• Transcranial dopplersTranscranial dopplers
Current recommendations……Current recommendations……
 Neonatal AIS – no therapyNeonatal AIS – no therapy
 Dissecting vasculopathy –Dissecting vasculopathy –
anticoagulation 3-6 monthsanticoagulation 3-6 months
 Cardiogenic embolism –Cardiogenic embolism –
anticoagulation but no consensus onanticoagulation but no consensus on
length of timelength of time
 Vasculopathy – ASA (no consensusVasculopathy – ASA (no consensus
on dose 1-5mg/kg/day)on dose 1-5mg/kg/day)
 Recurrent stroke – considerRecurrent stroke – consider
anticoagulationanticoagulation
HeparinHeparin
 For rapid anticoagulationFor rapid anticoagulation
 Bolus heparin 75-100u/kgBolus heparin 75-100u/kg
 Maintainence at 28 unit/kg/hr forMaintainence at 28 unit/kg/hr for
infantinfant
 20u/hr for >1 yr20u/hr for >1 yr
 Adjust APTT to 1.5 to 2Adjust APTT to 1.5 to 2
 Check APTT 4 hr after bolusCheck APTT 4 hr after bolus
 Daily APTT and CBCDaily APTT and CBC
LMW heparinLMW heparin
 LovenexLovenex
 1mg/kg in >1yr every 12 hr1mg/kg in >1yr every 12 hr
 1.5mg/kg in neonate1.5mg/kg in neonate
 Monitor by antifactorXa weeklyMonitor by antifactorXa weekly
AspirinAspirin
 3-5 mg/kg3-5 mg/kg
 Dose in less then 10% of antipyreticDose in less then 10% of antipyretic
dosedose
WarfarinWarfarin
 Used if secondary prevention withUsed if secondary prevention with
ASA failsASA fails
 Maintain INR of 2 to 3Maintain INR of 2 to 3
 In case of mechanical valve 2.5 toIn case of mechanical valve 2.5 to
3.53.5
Supportive treatmentSupportive treatment
 Manage ICTManage ICT
 Blood presureBlood presure
 Blood sugarBlood sugar
 Body temperatureBody temperature
 AntiepilepticAntiepileptic
 ImmunosuppresantImmunosuppresant
 TransfusionTransfusion
 NeurosurgeryNeurosurgery
 Interventional neuroradiological techniqueInterventional neuroradiological technique
 RehabilitationRehabilitation
 Acute stroke careAcute stroke care
OutcomeOutcome
 Mortality 20 to 30%Mortality 20 to 30%
 Residual neurological deficit in >50%Residual neurological deficit in >50%
 Risk of stroke recurrence is as highRisk of stroke recurrence is as high
as 20%as 20%
Differential DiagnosisDifferential Diagnosis
 MigraineMigraine
 Todds paralysisTodds paralysis

More Related Content

What's hot

Extrapyramidal System and Disorders of Extrapyramidal System
Extrapyramidal System and Disorders of Extrapyramidal SystemExtrapyramidal System and Disorders of Extrapyramidal System
Extrapyramidal System and Disorders of Extrapyramidal SystemChetan Ganteppanavar
 
Syringomyelia
SyringomyeliaSyringomyelia
SyringomyeliaSubbu Raj
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravischicks16
 
Motor neuron disease
Motor neuron diseaseMotor neuron disease
Motor neuron diseaseNeurologyKota
 
Cervical Fusion: C1-C2 Fusion
Cervical Fusion: C1-C2 FusionCervical Fusion: C1-C2 Fusion
Cervical Fusion: C1-C2 FusionFarrukh Javeed
 
Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy Ajay Kumar
 
Cranial nerve disorders
Cranial nerve disordersCranial nerve disorders
Cranial nerve disordersANILKUMAR BR
 
Extrapyramidal tracts and disorders
Extrapyramidal tracts and disordersExtrapyramidal tracts and disorders
Extrapyramidal tracts and disordersPriyanka Gupta
 
Myotonia- An approach to diagnosis
Myotonia- An approach to diagnosisMyotonia- An approach to diagnosis
Myotonia- An approach to diagnosisDr. Arghya Deb
 
Part 3 cranial nerve examination
Part 3 cranial nerve examinationPart 3 cranial nerve examination
Part 3 cranial nerve examinationAtul Saswat
 
Internal Medicine - Cerebrovascular Diseases
Internal Medicine - Cerebrovascular DiseasesInternal Medicine - Cerebrovascular Diseases
Internal Medicine - Cerebrovascular DiseasesNian Baring
 
Cerebellar examination
Cerebellar examination Cerebellar examination
Cerebellar examination rzgar hamed
 
Diseases of the spinal cord
Diseases of the spinal cordDiseases of the spinal cord
Diseases of the spinal cordHiba Hassan
 
Approach to dystonia
Approach to dystoniaApproach to dystonia
Approach to dystoniaNeurologyKota
 
Stroke Assessment & Rehabilitation
Stroke Assessment & RehabilitationStroke Assessment & Rehabilitation
Stroke Assessment & RehabilitationHimani Kaushik
 
Cervical Radiculopathy Power Point.ppt
Cervical Radiculopathy Power Point.pptCervical Radiculopathy Power Point.ppt
Cervical Radiculopathy Power Point.pptGenevieve Hall
 

What's hot (20)

Extrapyramidal System and Disorders of Extrapyramidal System
Extrapyramidal System and Disorders of Extrapyramidal SystemExtrapyramidal System and Disorders of Extrapyramidal System
Extrapyramidal System and Disorders of Extrapyramidal System
 
Syringomyelia
SyringomyeliaSyringomyelia
Syringomyelia
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravis
 
Motor neuron disease
Motor neuron diseaseMotor neuron disease
Motor neuron disease
 
Cervical Fusion: C1-C2 Fusion
Cervical Fusion: C1-C2 FusionCervical Fusion: C1-C2 Fusion
Cervical Fusion: C1-C2 Fusion
 
Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy Chronic inflammatory demyelinating Polyradiculoneuropathy
Chronic inflammatory demyelinating Polyradiculoneuropathy
 
Stroke syndromes
Stroke syndromesStroke syndromes
Stroke syndromes
 
Cranial nerve disorders
Cranial nerve disordersCranial nerve disorders
Cranial nerve disorders
 
Extrapyramidal tracts and disorders
Extrapyramidal tracts and disordersExtrapyramidal tracts and disorders
Extrapyramidal tracts and disorders
 
Myotonia- An approach to diagnosis
Myotonia- An approach to diagnosisMyotonia- An approach to diagnosis
Myotonia- An approach to diagnosis
 
foot drop
foot dropfoot drop
foot drop
 
Part 3 cranial nerve examination
Part 3 cranial nerve examinationPart 3 cranial nerve examination
Part 3 cranial nerve examination
 
Internal Medicine - Cerebrovascular Diseases
Internal Medicine - Cerebrovascular DiseasesInternal Medicine - Cerebrovascular Diseases
Internal Medicine - Cerebrovascular Diseases
 
Cerebellar examination
Cerebellar examination Cerebellar examination
Cerebellar examination
 
Facial palsy
Facial palsyFacial palsy
Facial palsy
 
Diseases of the spinal cord
Diseases of the spinal cordDiseases of the spinal cord
Diseases of the spinal cord
 
Approach to dystonia
Approach to dystoniaApproach to dystonia
Approach to dystonia
 
Stroke Assessment & Rehabilitation
Stroke Assessment & RehabilitationStroke Assessment & Rehabilitation
Stroke Assessment & Rehabilitation
 
Spinal cord injury.pptx
Spinal cord injury.pptxSpinal cord injury.pptx
Spinal cord injury.pptx
 
Cervical Radiculopathy Power Point.ppt
Cervical Radiculopathy Power Point.pptCervical Radiculopathy Power Point.ppt
Cervical Radiculopathy Power Point.ppt
 

Viewers also liked

Viewers also liked (10)

Approach to hemiplegia
Approach to hemiplegiaApproach to hemiplegia
Approach to hemiplegia
 
Headache
HeadacheHeadache
Headache
 
Cns clinical evaluation of hemiplegia slideshare upload
Cns   clinical evaluation of hemiplegia slideshare uploadCns   clinical evaluation of hemiplegia slideshare upload
Cns clinical evaluation of hemiplegia slideshare upload
 
Hemiplegia
HemiplegiaHemiplegia
Hemiplegia
 
Stroke (cerebrovascular accident)
Stroke (cerebrovascular accident)Stroke (cerebrovascular accident)
Stroke (cerebrovascular accident)
 
Meningioma final
Meningioma finalMeningioma final
Meningioma final
 
Hemiplegia (1)
Hemiplegia (1)Hemiplegia (1)
Hemiplegia (1)
 
Approach to a patient with stroke
Approach to a patient with stroke Approach to a patient with stroke
Approach to a patient with stroke
 
Hemiplegia
HemiplegiaHemiplegia
Hemiplegia
 
Stroke: PT Assessment and Management
Stroke: PT Assessment and Management Stroke: PT Assessment and Management
Stroke: PT Assessment and Management
 

Similar to Hemiplegia stroke

Cerebrovascular Accident CVA (Stroke), Angin Ahmar (malay)
Cerebrovascular Accident CVA (Stroke), Angin Ahmar (malay)Cerebrovascular Accident CVA (Stroke), Angin Ahmar (malay)
Cerebrovascular Accident CVA (Stroke), Angin Ahmar (malay)edge ryan
 
VENTRICULAR SEPTAL DEFECT
VENTRICULAR SEPTAL DEFECTVENTRICULAR SEPTAL DEFECT
VENTRICULAR SEPTAL DEFECTVikas Kumar
 
Dr Indranil Dutta vascular anomaly ppt
Dr Indranil Dutta vascular anomaly pptDr Indranil Dutta vascular anomaly ppt
Dr Indranil Dutta vascular anomaly pptINDRANIL DUTTA
 
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02Afroza Prioty
 
Heart failure syndrome1
Heart failure syndrome1Heart failure syndrome1
Heart failure syndrome1asadsoomro1960
 
cerebral venous sinus thrombosis.pptx
cerebral venous sinus thrombosis.pptxcerebral venous sinus thrombosis.pptx
cerebral venous sinus thrombosis.pptxmohamed elshafei
 
Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016pathologydept
 
Essentials of pediatric trauma care short september 2012
Essentials of pediatric trauma care short september 2012Essentials of pediatric trauma care short september 2012
Essentials of pediatric trauma care short september 2012James Cain
 
Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8Dr Khalid Hasan Khan
 
Evaluation and management of epilpesy
Evaluation and management of epilpesyEvaluation and management of epilpesy
Evaluation and management of epilpesySudhir Kumar
 
Cva5 cerebralvascularaccident
Cva5 cerebralvascularaccidentCva5 cerebralvascularaccident
Cva5 cerebralvascularaccidentG D P A CHOWDARY
 
Management of Intercranial Pressure
Management of Intercranial PressureManagement of Intercranial Pressure
Management of Intercranial PressureDr.Mahmoud Abbas
 

Similar to Hemiplegia stroke (20)

Cerebrovascular Accident CVA (Stroke), Angin Ahmar (malay)
Cerebrovascular Accident CVA (Stroke), Angin Ahmar (malay)Cerebrovascular Accident CVA (Stroke), Angin Ahmar (malay)
Cerebrovascular Accident CVA (Stroke), Angin Ahmar (malay)
 
VENTRICULAR SEPTAL DEFECT
VENTRICULAR SEPTAL DEFECTVENTRICULAR SEPTAL DEFECT
VENTRICULAR SEPTAL DEFECT
 
Dr Indranil Dutta vascular anomaly ppt
Dr Indranil Dutta vascular anomaly pptDr Indranil Dutta vascular anomaly ppt
Dr Indranil Dutta vascular anomaly ppt
 
Pituitary
PituitaryPituitary
Pituitary
 
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
 
Heart failure syndrome1
Heart failure syndrome1Heart failure syndrome1
Heart failure syndrome1
 
cerebral venous sinus thrombosis.pptx
cerebral venous sinus thrombosis.pptxcerebral venous sinus thrombosis.pptx
cerebral venous sinus thrombosis.pptx
 
Pediatric hypertension
Pediatric hypertensionPediatric hypertension
Pediatric hypertension
 
Paediatric oncology
Paediatric oncologyPaediatric oncology
Paediatric oncology
 
Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016
 
Essentials of pediatric trauma care short september 2012
Essentials of pediatric trauma care short september 2012Essentials of pediatric trauma care short september 2012
Essentials of pediatric trauma care short september 2012
 
Onc emergencies
Onc emergenciesOnc emergencies
Onc emergencies
 
32583 myopathy heridatery
32583 myopathy heridatery32583 myopathy heridatery
32583 myopathy heridatery
 
Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8
 
Evaluation and management of epilpesy
Evaluation and management of epilpesyEvaluation and management of epilpesy
Evaluation and management of epilpesy
 
Paediatric stroke
Paediatric strokePaediatric stroke
Paediatric stroke
 
Sudden SNHL
Sudden SNHLSudden SNHL
Sudden SNHL
 
Cva5 cerebralvascularaccident
Cva5 cerebralvascularaccidentCva5 cerebralvascularaccident
Cva5 cerebralvascularaccident
 
CEREBRO VASCULAR DISEASE
CEREBRO VASCULAR DISEASECEREBRO VASCULAR DISEASE
CEREBRO VASCULAR DISEASE
 
Management of Intercranial Pressure
Management of Intercranial PressureManagement of Intercranial Pressure
Management of Intercranial Pressure
 

Recently uploaded

Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Exploring the Variety of Private Blood Tests in the UK
Exploring the Variety of Private Blood Tests in the UKExploring the Variety of Private Blood Tests in the UK
Exploring the Variety of Private Blood Tests in the UKPrivate GP London
 
Next Gen Ophthalmic Imaging for Neurodegenerative Diseases and Oculomics
Next Gen Ophthalmic Imaging for Neurodegenerative Diseases and OculomicsNext Gen Ophthalmic Imaging for Neurodegenerative Diseases and Oculomics
Next Gen Ophthalmic Imaging for Neurodegenerative Diseases and OculomicsPetteriTeikariPhD
 
NEWER OHAs AND NEWER INSULIN.pptx
NEWER OHAs        AND NEWER INSULIN.pptxNEWER OHAs        AND NEWER INSULIN.pptx
NEWER OHAs AND NEWER INSULIN.pptxtarakeeshbai1802
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
SGK NĂNG LƯỢNG SINH HỌC MỚI 2019 RẤT HAY NHÉ.pdf
SGK NĂNG LƯỢNG SINH HỌC MỚI 2019 RẤT HAY NHÉ.pdfSGK NĂNG LƯỢNG SINH HỌC MỚI 2019 RẤT HAY NHÉ.pdf
SGK NĂNG LƯỢNG SINH HỌC MỚI 2019 RẤT HAY NHÉ.pdfHongBiThi1
 
23470206-Esophageal-Cancer.ppt for medical surgical nursing
23470206-Esophageal-Cancer.ppt for medical surgical nursing23470206-Esophageal-Cancer.ppt for medical surgical nursing
23470206-Esophageal-Cancer.ppt for medical surgical nursingakoeljames8543
 
CPCSEA guidelines and IAEC committee.pptx
CPCSEA guidelines and IAEC committee.pptxCPCSEA guidelines and IAEC committee.pptx
CPCSEA guidelines and IAEC committee.pptxMs. Kiran Divekar
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxSasikiranMarri
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Dr. Dheeraj Kumar
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Rapid Release Granulation Technology ppt
Rapid Release Granulation Technology pptRapid Release Granulation Technology ppt
Rapid Release Granulation Technology pptHasnat Tariq
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfHongBiThi1
 
Aditi Jagtap (Daughter of Ranjit Jagtap).pdf
Aditi Jagtap (Daughter of Ranjit Jagtap).pdfAditi Jagtap (Daughter of Ranjit Jagtap).pdf
Aditi Jagtap (Daughter of Ranjit Jagtap).pdfAditi Jagtap Pune
 

Recently uploaded (20)

Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Exploring the Variety of Private Blood Tests in the UK
Exploring the Variety of Private Blood Tests in the UKExploring the Variety of Private Blood Tests in the UK
Exploring the Variety of Private Blood Tests in the UK
 
Next Gen Ophthalmic Imaging for Neurodegenerative Diseases and Oculomics
Next Gen Ophthalmic Imaging for Neurodegenerative Diseases and OculomicsNext Gen Ophthalmic Imaging for Neurodegenerative Diseases and Oculomics
Next Gen Ophthalmic Imaging for Neurodegenerative Diseases and Oculomics
 
NEWER OHAs AND NEWER INSULIN.pptx
NEWER OHAs        AND NEWER INSULIN.pptxNEWER OHAs        AND NEWER INSULIN.pptx
NEWER OHAs AND NEWER INSULIN.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
SGK NĂNG LƯỢNG SINH HỌC MỚI 2019 RẤT HAY NHÉ.pdf
SGK NĂNG LƯỢNG SINH HỌC MỚI 2019 RẤT HAY NHÉ.pdfSGK NĂNG LƯỢNG SINH HỌC MỚI 2019 RẤT HAY NHÉ.pdf
SGK NĂNG LƯỢNG SINH HỌC MỚI 2019 RẤT HAY NHÉ.pdf
 
23470206-Esophageal-Cancer.ppt for medical surgical nursing
23470206-Esophageal-Cancer.ppt for medical surgical nursing23470206-Esophageal-Cancer.ppt for medical surgical nursing
23470206-Esophageal-Cancer.ppt for medical surgical nursing
 
CPCSEA guidelines and IAEC committee.pptx
CPCSEA guidelines and IAEC committee.pptxCPCSEA guidelines and IAEC committee.pptx
CPCSEA guidelines and IAEC committee.pptx
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Rapid Release Granulation Technology ppt
Rapid Release Granulation Technology pptRapid Release Granulation Technology ppt
Rapid Release Granulation Technology ppt
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
 
Aditi Jagtap (Daughter of Ranjit Jagtap).pdf
Aditi Jagtap (Daughter of Ranjit Jagtap).pdfAditi Jagtap (Daughter of Ranjit Jagtap).pdf
Aditi Jagtap (Daughter of Ranjit Jagtap).pdf
 

Hemiplegia stroke

  • 1. Acute onset hemiplegiaAcute onset hemiplegia Dr Surya KumarDr Surya Kumar
  • 2.  Paralysis of one half of the bodyParalysis of one half of the body CompleteComplete IncompleteIncomplete CrossedCrossed
  • 4.
  • 5. PhysiologyPhysiology  CMRoCMRo22 is 3.5ml/100mgis 3.5ml/100mg  Glucose storage upto 90 minGlucose storage upto 90 min  CBF 30-60ml/100mg <3yrCBF 30-60ml/100mg <3yr  105-100ml/100mg in 3 -10 yr105-100ml/100mg in 3 -10 yr
  • 6.  2.5-2.7/100,000 population2.5-2.7/100,000 population IncidenceIncidence
  • 7. EtiologyEtiology  Cardiac ---CCHD, IE, RHD, MyxomaCardiac ---CCHD, IE, RHD, Myxoma  Blood dyscrasia---Blood dyscrasia---  Primary vascular disease AcutePrimary vascular disease Acute infantile hemiplegia, MoyaMoya, Takayasu,infantile hemiplegia, MoyaMoya, Takayasu, hemiplegic Migraine, fibromuscularhemiplegic Migraine, fibromuscular Dysplasia,Dysplasia,  Collagen Vascular Disease PAN,Collagen Vascular Disease PAN, SLESLE  Infectious DiseaseInfectious Disease 
  • 8.  Metabolic DiseaseMetabolic Disease Homocystinuria,MELAsHomocystinuria,MELAs  TraumaTrauma Carotid Dissection, Air Embolism, FatCarotid Dissection, Air Embolism, Fat Embolism, Vertebral occlusionEmbolism, Vertebral occlusion  Vascular MalformationVascular Malformation Aneurysm, arteriovenous Malformation,Aneurysm, arteriovenous Malformation, Vein of galen malformation,Vein of galen malformation,  Neurocutaneous syndromeNeurocutaneous syndrome Sturge WeberSturge Weber
  • 9.  IschemicIschemic  HemorragicHemorragic  Share equal proportion of incidenceShare equal proportion of incidence
  • 10. Ischemic strokeIschemic stroke  Cardiac disease 19%Cardiac disease 19%  Coagulation Disorder 14%Coagulation Disorder 14%  Dehydration 11%Dehydration 11%  Infection 6%Infection 6%  Vasculitis 7%Vasculitis 7%  Dissection 5%Dissection 5%  Cancer 4%Cancer 4%  Metabolic disorder 3%Metabolic disorder 3%  Moyamoya ,SCA, 2%Moyamoya ,SCA, 2%  MISC 4%MISC 4%  No risk factor 21%No risk factor 21%
  • 11. AISAIS Vulnerable sitesVulnerable sites  DiencephalonDiencephalon  Watershed aresWatershed ares
  • 12. SymptomsSymptoms  Focal neurological deficitFocal neurological deficit  SeizureSeizure  MigraineMigraine  FeverFever  LethargyLethargy  HeadacheHeadache  DYstoniaDYstonia  Age relate and associted conditionsAge relate and associted conditions
  • 13. Cadiac disorderCadiac disorder  CHDCHD  RHDRHD  Prosthetic ValveProsthetic Valve  Shunts,Shunts,  Patent foramen ovalePatent foramen ovale
  • 14. causescauses  PolycythemiaPolycythemia  AnemiaAnemia  ArrythmiaArrythmia  EndocarditisEndocarditis
  • 15. IncidenceIncidence  Exact Data is not availableExact Data is not available  Upto 9% undergoing fontan surgeryUpto 9% undergoing fontan surgery  50% occurred within 72 hr of50% occurred within 72 hr of surgerysurgery
  • 16. Hematological and hypercoagubleHematological and hypercoaguble statesstates  22ndnd most important causemost important cause  2 to 7% of young patient2 to 7% of young patient  Factor v leiden mutation,Factor v leiden mutation, homocystinemia, deficiency ofhomocystinemia, deficiency of protein c and protein sprotein c and protein s
  • 17. Sickle cell anemiaSickle cell anemia  300per 100,000 sickle cell patient300per 100,000 sickle cell patient  Above 5 yrAbove 5 yr Silent infarcts are presentSilent infarcts are present  Associated with seizures, cranialAssociated with seizures, cranial nerves ,cognitive declinenerves ,cognitive decline  Prone for recuurences, chronicProne for recuurences, chronic seizure disorderseizure disorder
  • 18.  Keep good hydrationKeep good hydration  Transfusion to keep HbS <30%Transfusion to keep HbS <30%
  • 19. InfectionInfection  5 to 12 % of meningitis5 to 12 % of meningitis  Systemic infectionSystemic infection post varicella angiopathy,post varicella angiopathy, pneumonia, borrelia, HIV,pneumonia, borrelia, HIV, helicobacter,helicobacter,  May occur after weeks to months ofMay occur after weeks to months of infectioninfection  Post varicellea and herpes isPost varicellea and herpes is commoncommon
  • 20. Moya moyaMoya moya  Chronic,prgrssive,stenotic disease ofChronic,prgrssive,stenotic disease of arteryartery  Mainly females are involved. 6 timesMainly females are involved. 6 times  Multiple telengtesia seen in brainMultiple telengtesia seen in brain mainly in basal ganglonmainly in basal ganglon  seizure seen in 335 of patientsseizure seen in 335 of patients  Recurrent ischemic attack, mentalRecurrent ischemic attack, mental retardation,,infarction on CTretardation,,infarction on CT  Treatment is surgeryTreatment is surgery
  • 21. vasculitisvasculitis  Takayasu, SLE, MCTD,PANTakayasu, SLE, MCTD,PAN  Present with associated symptomsPresent with associated symptoms  Steroid and immunotherapySteroid and immunotherapy
  • 22. MetabolicMetabolic  Homocystenemia, MELA, FamilialHomocystenemia, MELA, Familial HypercholesteremiaHypercholesteremia  Family history, and charactersticsFamily history, and characterstics featurefeature
  • 23. MigraineMigraine  More common in femalesMore common in females  FamilialFamilial  Occasionaly permanent deficitOccasionaly permanent deficit
  • 24. TraumaTrauma  Dissecting aneurysm in arteryDissecting aneurysm in artery  Barbershop,fall on pencil in mouth,Barbershop,fall on pencil in mouth, popstick,barbershoppopstick,barbershop  Symtoms come after 1 to 2 daysSymtoms come after 1 to 2 days
  • 26. Risk factorsRisk factors  Prothrombotic disorder 30%Prothrombotic disorder 30%  Dehydration 30%Dehydration 30%  Sysystemic infection 8-10%Sysystemic infection 8-10%  Head and neck infection 9%Head and neck infection 9%  Rest by cardiac, leukemia,perinatalRest by cardiac, leukemia,perinatal complication, Drugscomplication, Drugs
  • 27. featuresfeatures  Seizures, lethargy,jitterySeizures, lethargy,jittery  Dilated scalp veins, anterior fontanel,Dilated scalp veins, anterior fontanel, eyelid swellingeyelid swelling  Headche,Headche,
  • 28. OutcomeOutcome  53% normal53% normal  25% neurological deficit and seizure25% neurological deficit and seizure  5% seizure alone5% seizure alone  9% died9% died  Perspective study of 80 infantsPerspective study of 80 infants
  • 29. hemorrhagehemorrhage  Congenital vascular anamolyCongenital vascular anamoly  VasculopathiesVasculopathies  Systemic diseaseSystemic disease  TraumaTrauma  Hematological disodersHematological disoders
  • 30. Intracerebral hemorrhageIntracerebral hemorrhage  At the entry point of brainAt the entry point of brain  Hematoma and cerebral edemaHematoma and cerebral edema produces mass like lesionproduces mass like lesion
  • 31. FeaturesFeatures  Severe headache,Severe headache,  SeizuresSeizures  Focal signsFocal signs  Decrease in conciousnessDecrease in conciousness  AtaxiaAtaxia  Dysconjugate gaitDysconjugate gait  comacoma
  • 32. Risk factorRisk factor  Trauma most commonTrauma most common  Vascular malformationVascular malformation  Degenerative vasculopathyDegenerative vasculopathy  Hemophilic disorderHemophilic disorder
  • 33. Subarachnoid hemoorrhageSubarachnoid hemoorrhage  Ateries forming circle of willis andAteries forming circle of willis and surrounding itsurrounding it  Circle of willis seen more in adulutCircle of willis seen more in adulut
  • 34.  Erythrocytes in subarachnoid spaceErythrocytes in subarachnoid space can cause severe spasm leading tocan cause severe spasm leading to secondary ishemic infarctionsecondary ishemic infarction
  • 35. FeatureFeature  Severe headache, neck rigidity,Severe headache, neck rigidity,  Low grade feverLow grade fever  LeckocytosisLeckocytosis  Raised ICTRaised ICT
  • 36. Malformation of vein of galenMalformation of vein of galen
  • 37. ApporachApporach  Through examinationThrough examination  HeaHea  FaceFace  EyesEyes  EarsEars  Paranasal sinusesParanasal sinuses  Oral cavityOral cavity  neckneck
  • 38.  SkinSkin  Bone and jointsBone and joints  ExtremitiesExtremities  AnthropometryAnthropometry  vitalsvitals
  • 39.  Per abdomenPer abdomen  CVSCVS  Suppurative lung diseaseSuppurative lung disease
  • 40. InvestigationInvestigation  CBC,Platelet,ESRCBC,Platelet,ESR  LFTLFT  CholesterolCholesterol  Coagulation profileCoagulation profile  ECG, chest X xay,ECG, chest X xay,  USG abdomenUSG abdomen  VDRL/HIVVDRL/HIV  UrinanalysisUrinanalysis  Lactate/pyruvateLactate/pyruvate
  • 41.  Ana,RA, anti cardiolipinAna,RA, anti cardiolipin  Lumbar puntureLumbar punture  CTCT  MRIMRI  AngiographyAngiography
  • 42. TherapyTherapy  Absence of RCTAbsence of RCT  Adapted from adultsAdapted from adults  Treat underlying risk factorTreat underlying risk factor  Prevent recurrencePrevent recurrence
  • 43. Consensus on……Consensus on……  Sickle cell diseaseSickle cell disease  Acute therapyAcute therapy • Exchange transfusionExchange transfusion  Preventive therapyPreventive therapy • Blood transfusion every 3-6 weeks toBlood transfusion every 3-6 weeks to maintain HbS<30%maintain HbS<30% • ?HU, stem cell transplant?HU, stem cell transplant • Transcranial dopplersTranscranial dopplers
  • 44. Current recommendations……Current recommendations……  Neonatal AIS – no therapyNeonatal AIS – no therapy  Dissecting vasculopathy –Dissecting vasculopathy – anticoagulation 3-6 monthsanticoagulation 3-6 months  Cardiogenic embolism –Cardiogenic embolism – anticoagulation but no consensus onanticoagulation but no consensus on length of timelength of time  Vasculopathy – ASA (no consensusVasculopathy – ASA (no consensus on dose 1-5mg/kg/day)on dose 1-5mg/kg/day)  Recurrent stroke – considerRecurrent stroke – consider anticoagulationanticoagulation
  • 45. HeparinHeparin  For rapid anticoagulationFor rapid anticoagulation  Bolus heparin 75-100u/kgBolus heparin 75-100u/kg  Maintainence at 28 unit/kg/hr forMaintainence at 28 unit/kg/hr for infantinfant  20u/hr for >1 yr20u/hr for >1 yr  Adjust APTT to 1.5 to 2Adjust APTT to 1.5 to 2  Check APTT 4 hr after bolusCheck APTT 4 hr after bolus  Daily APTT and CBCDaily APTT and CBC
  • 46. LMW heparinLMW heparin  LovenexLovenex  1mg/kg in >1yr every 12 hr1mg/kg in >1yr every 12 hr  1.5mg/kg in neonate1.5mg/kg in neonate  Monitor by antifactorXa weeklyMonitor by antifactorXa weekly
  • 47. AspirinAspirin  3-5 mg/kg3-5 mg/kg  Dose in less then 10% of antipyreticDose in less then 10% of antipyretic dosedose
  • 48. WarfarinWarfarin  Used if secondary prevention withUsed if secondary prevention with ASA failsASA fails  Maintain INR of 2 to 3Maintain INR of 2 to 3  In case of mechanical valve 2.5 toIn case of mechanical valve 2.5 to 3.53.5
  • 49. Supportive treatmentSupportive treatment  Manage ICTManage ICT  Blood presureBlood presure  Blood sugarBlood sugar  Body temperatureBody temperature  AntiepilepticAntiepileptic  ImmunosuppresantImmunosuppresant  TransfusionTransfusion  NeurosurgeryNeurosurgery  Interventional neuroradiological techniqueInterventional neuroradiological technique  RehabilitationRehabilitation  Acute stroke careAcute stroke care
  • 50. OutcomeOutcome  Mortality 20 to 30%Mortality 20 to 30%  Residual neurological deficit in >50%Residual neurological deficit in >50%  Risk of stroke recurrence is as highRisk of stroke recurrence is as high as 20%as 20%
  • 51. Differential DiagnosisDifferential Diagnosis  MigraineMigraine  Todds paralysisTodds paralysis